Kevin T. Conroy, President and CEO at EXACT SCIENCES CORP (EXAS), sold 7 shares at $40.75 ($285) on 2022-07-01, disclosed to the SEC on 2022-07-06.
Scheduled sale ($285) by President and CEO under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| Filing → |
| EXAS | SELL | 2024-03-04 | $981K | — | Filing → |
| EXAS | SELL | 2024-02-28 | $713K | — | Filing → |
| EXAS | SELL | 2024-02-23 | $1.4M | — | Filing → |